feedproxy.google.com
CAFC: Claim Construction That Misreads Plain Language of Claims and Specification Is Clearly Erroneous
The CAFC recently vacated a district court decision which found a patent for the antipsychotic drug “Saphris,” belonging to Forest Laboratories, valid as nonobvious, but not infringed by ANDA filers Alembic Pharmaceuticals Ltd. and Breckenridge Pharmaceuticals, Inc.